[go: up one dir, main page]

NO20031697L - Nye m-amino-fenylimino-imidazolin-derivater for behandling av urininkontinens - Google Patents

Nye m-amino-fenylimino-imidazolin-derivater for behandling av urininkontinens

Info

Publication number
NO20031697L
NO20031697L NO20031697A NO20031697A NO20031697L NO 20031697 L NO20031697 L NO 20031697L NO 20031697 A NO20031697 A NO 20031697A NO 20031697 A NO20031697 A NO 20031697A NO 20031697 L NO20031697 L NO 20031697L
Authority
NO
Norway
Prior art keywords
phenylimino
amino
treatment
new
urinary incontinence
Prior art date
Application number
NO20031697A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031697D0 (no
Inventor
Franz Esser
Jane-Josee Arielle Pasc Pouzet
Hisato Kitagawa
Keiji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20031697D0 publication Critical patent/NO20031697D0/no
Publication of NO20031697L publication Critical patent/NO20031697L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031697A 2000-10-14 2003-04-11 Nye m-amino-fenylimino-imidazolin-derivater for behandling av urininkontinens NO20031697L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (2)

Publication Number Publication Date
NO20031697D0 NO20031697D0 (no) 2003-04-11
NO20031697L true NO20031697L (no) 2003-05-26

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031697A NO20031697L (no) 2000-10-14 2003-04-11 Nye m-amino-fenylimino-imidazolin-derivater for behandling av urininkontinens

Country Status (23)

Country Link
EP (1) EP1328517A2 (xx)
JP (1) JP2004511547A (xx)
KR (1) KR20030046503A (xx)
CN (1) CN1471514A (xx)
AR (1) AR035923A1 (xx)
AU (1) AU2002215943A1 (xx)
BG (1) BG107711A (xx)
BR (1) BR0114603A (xx)
CA (1) CA2425563A1 (xx)
CZ (1) CZ20031333A3 (xx)
DE (1) DE10150312A1 (xx)
EA (1) EA200300460A1 (xx)
EC (1) ECSP034517A (xx)
EE (1) EE200300177A (xx)
HU (1) HUP0302245A3 (xx)
IL (1) IL155338A0 (xx)
MX (1) MXPA03003162A (xx)
NO (1) NO20031697L (xx)
PL (1) PL361359A1 (xx)
SK (1) SK4342003A3 (xx)
WO (1) WO2002032876A2 (xx)
YU (1) YU28203A (xx)
ZA (1) ZA200302345B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
KR20030046503A (ko) 2003-06-12
NO20031697D0 (no) 2003-04-11
DE10150312A1 (de) 2002-07-04
MXPA03003162A (es) 2004-12-06
SK4342003A3 (en) 2003-10-07
ECSP034517A (es) 2003-04-25
HUP0302245A2 (hu) 2003-10-28
ZA200302345B (en) 2004-04-23
WO2002032876A2 (de) 2002-04-25
CA2425563A1 (en) 2002-04-25
AU2002215943A1 (en) 2002-04-29
CZ20031333A3 (cs) 2003-08-13
HUP0302245A3 (en) 2004-01-28
EA200300460A1 (ru) 2004-02-26
EP1328517A2 (de) 2003-07-23
AR035923A1 (es) 2004-07-28
CN1471514A (zh) 2004-01-28
EE200300177A (et) 2003-08-15
JP2004511547A (ja) 2004-04-15
IL155338A0 (en) 2003-11-23
YU28203A (sh) 2006-05-25
BG107711A (bg) 2004-02-27
WO2002032876A3 (de) 2002-07-18
BR0114603A (pt) 2003-10-14
PL361359A1 (en) 2004-10-04

Similar Documents

Publication Publication Date Title
NO20014960D0 (no) Nye fremgangsmåter for behandling
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20024005L (no) Pteridinforbindelser for behandling av psoriasis
IL229160B (en) Rapamycin derivatives for treatment of solid tumors
NO20014950D0 (no) Nye behandlingsmetoder
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
PT1413305E (pt) Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria
NO20030978L (no) Behandling av urindysfunksjon
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
NO20012569D0 (no) Anvendelse av aryl-substituerte syklobutylaminer for behandling av urininkontinens
NO20033368D0 (no) Nye alkyl-fenylimino-imidazolidin-derivater for behandling av urin-inkontinens
NO20031697D0 (no) Nye M-amino-fenylimino-imidazolinderivater for behandling av urininkontinens
AU2002223688A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
FI964019L (fi) Kinolonijohdannainen virtsainkontinenssin hoitoon
NO20033428L (no) Anvendelse av 2-amino-1(4-hydroksy-3-metansulfonamidofenyl)- etanol for behandling av urin-inkontinens
NO20014476D0 (no) Behandling av hiatial hernia
SI1413305T1 (sl) Aril (ali heteroaril) azolikarbonil derivati za zdravljenje urinske inkontinence
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application